Acubro Tablets are a medication formulated with a combination of Acebrophylline and Montelukast, primarily used for the treatment and prevention of various respiratory disorders.

Acubro Tablets are specifically indicated for respiratory conditions like asthma, COPD, and allergic rhinitis. They are not typically used for other unrelated conditions.

Acubro Tablets are not typically used as a rescue medication for acute asthma attacks. They are more commonly used for long-term management and prevention of asthma symptoms. Short-acting bronchodilators are usually prescribed for immediate relief during asthma attacks.

The dosage of Acubro Tablets varies depending on the specific condition being treated and individual patient factors. It is important to follow the dosage instructions provided by your doctor. Do not adjust the dosage without consulting your doctor.

Acubro Tablets contain Acebrophylline and Montelukast as active ingredients. Acebrophylline is a bronchodilator and mucolytic agent, while Montelukast is a leukotriene receptor antagonist.

Acubro Tablets may be used in children under the supervision of a doctor, depending on the specific condition being treated and the child's age. The dosage and safety considerations may differ for pediatric use.